Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Melinta Therapeutics, Inc. (NASDAQ: MLNT).

Full DD Report for MLNT

You must become a subscriber to view this report.


Recent News from (NASDAQ: MLNT)

Premarket analyst action - healthcare
Melinta Therapeutics (NASDAQ: MLNT ) initiated with Buy rating and $15 (249% upside) price target at Jefferies. Shares up  12%  premarket. More news on: Melinta Therapeutics, Tabula Rasa HealthCare, Endo International plc, Healthcare stocks news, Stocks on the move, , Read mo...
Source: SeekingAlpha
Date: September, 11 2018 08:20
Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference
NEW HAVEN, Conn., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that the company will be attending and hosting meet...
Source: GlobeNewswire
Date: September, 06 2018 08:00

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-144.404.354.554.25272,493

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-0766,108161,62840.9013Short
2018-12-0676,765142,42953.8970Short
2018-12-0475,091176,85542.4591Short
2018-12-0348,28799,83448.3673Short
2018-11-30114,534217,59952.6354Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on MLNT.


About Melinta Therapeutics, Inc. (NASDAQ: MLNT)

Logo for Melinta Therapeutics, Inc. (NASDAQ: MLNT)

Not available

 

Contact Information

     

     

    Current Share Structure

    • Market Cap: $77,710,989 - 05/17/2018
    • Issue and Outstanding: 10,501,485 - 11/06/2017

     


    Recent Filings from (NASDAQ: MLNT)

    Amendment to the SC 13G filing
    Filing Type: SC 13G/AFiling Source: edgar
    Filing Date: September, 10 2018
    Securities offered to employees under employee benefit plans
    Filing Type: S-8Filing Source: edgar
    Filing Date: September, 04 2018
    Securities offered to employees under employee benefit plans
    Filing Type: S-8Filing Source: edgar
    Filing Date: September, 04 2018
    Quarterly report with a continuing view of a company's financial position
    Filing Type: 10-QFiling Source: edgar
    Filing Date: August, 09 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: August, 07 2018
    Report of unscheduled material events or corporate changes.
    Filing Type: 8-KFiling Source: edgar
    Filing Date: June, 14 2018
    Filing Type: CT ORDERFiling Source: edgar
    Filing Date: June, 11 2018
    Statement of beneficial ownership of common stock by certain persons
    Filing Type: SC 13GFiling Source: edgar
    Filing Date: June, 11 2018
    Amendment to a previously filed 8-K
    Filing Type: 8-K/AFiling Source: edgar
    Filing Date: June, 08 2018
    Amendment to a SC 13D filing
    Filing Type: SC 13D/AFiling Source: edgar
    Filing Date: May, 31 2018

     

     


    Daily Technical Chart for (NASDAQ: MLNT)

    Daily Technical Chart for (NASDAQ: MLNT)


    Stay tuned for daily updates and more on (NASDAQ: MLNT)

    It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

    More to come on (NASDAQ: MLNT)

    Do your DD and if you choose, be ready to go!


     

    The Research: All source information contained in this email is from the public sources mentioned below.

     

     
     

    Thank you

    DD Report
    @DDReports

     

     


    Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in MLNT is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of MLNT and does not buy, sell, or trade any shares of MLNT. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/